Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan;38(1):146-159.
doi: 10.1002/stem.3077. Epub 2019 Sep 10.

Integrated transcriptomic, phenotypic, and functional study reveals tissue-specific immune properties of mesenchymal stromal cells

Cédric Ménard  1   2 , Joëlle Dulong  1   2 , David Roulois  1 , Benjamin Hébraud  3 , Léa Verdière  1 , Céline Pangault  1   4 , Vonick Sibut  1   2 , Isabelle Bezier  1   2 , Nadège Bescher  1   2 , Céline Monvoisin  1 , Mélanie Gadelorge  3 , Nicolas Bertheuil  2   5 , Erwan Flécher  6 , Louis Casteilla  3 , Philippe Collas  7 , Luc Sensebé  3 , Philippe Bourin  8 , Nicolas Espagnolle  3 , Karin Tarte  1   2
Affiliations
Free article

Integrated transcriptomic, phenotypic, and functional study reveals tissue-specific immune properties of mesenchymal stromal cells

Cédric Ménard et al. Stem Cells. 2020 Jan.
Free article

Abstract

Clinical-grade mesenchymal stromal cells (MSCs) can be expanded from bone marrow and adipose tissue to treat inflammatory diseases and degenerative disorders. However, the influence of their tissue of origin on their functional properties, including their immunosuppressive activity, remains unsolved. In this study, we produced paired bone marrow-derived mesenchymal stromal cell (BM-MSC) and adipose-derived stromal cell (ASC) batches from 14 healthy donors. We then compared them using transcriptomic, phenotypic, and functional analyses and validated our results on purified native MSCs to infer which differences were really endowed by tissue of origin. Cultured MSCs segregated together owing to their tissue of origin based on their gene expression profile analyzed using differential expression and weighted gene coexpression network analysis. This translated into distinct immune-related gene signatures, phenotypes, and functional cell interactions. Importantly, sorted native BM-MSCs and ASCs essentially displayed the same distinctive patterns than their in vitro-expanded counterparts. As a whole, ASCs exhibited an immune profile consistent with a stronger inhibition of immune response and a lower immunogenicity, supporting the use of adipose tissue as a valuable source for clinical applications.

Keywords: adipose stem cells; bone marrow stromal cells (BMSCs); cell interactions; gene expression; immunosuppression, immunogenicity.

PubMed Disclaimer

References

REFERENCES

    1. Shi Y, Wang Y, Li Q, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol 2018;14:493-507.
    1. Galipeau J, Sensebé L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell 2018;22:824-833.
    1. Galipeau J. The mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy 2013;15:2-8.
    1. Sensebé L, Bourin P, Tarte K. Good manufacturing practices production of mesenchymal stem/stromal cells. Hum Gene Ther 2011;22:19-26.
    1. Mendicino M, Bailey AM, Wonnacott K, et al. MSC-based product characterization for clinical trials: an FDA perspective. Cell Stem Cell 2014;14:141-145.

Publication types